Skip to content 
An enlightening discussion with Dr. Amal Hagos, a pain management specialist at Aurea Care in Stockholm, on the complexities and future of medical cannabis in treating chronic pain. This interview dives into evidence-based practices, the endocannabinoid system, ethical considerations, and much more.
In a revealing international survey, Syed et al. delve into the knowledge, attitudes, and practices of physicians regarding medical cannabis. With responses from 17 countries, the study uncovers significant gaps in understanding and highlights the urgent need for enhanced medical education on this topic.
The Stockholm Medical Cannabis Conference, organized by Aureum Life, aims to challenge Sweden’s stringent drug policies amidst an escalating crisis. With an emphasis on education and open dialogue, the conference is a potential pivot point, opening up pathways for a new understanding of the therapeutic potential of cannabis.
Explore the nuanced understanding of the ‘high’ associated with medical cannabis use. This article, based on a recent study, challenges traditional perceptions and invites readers to consider the ‘high’ as a separate phenomenon that may not interfere with the therapeutic benefits of cannabis.
Exploring the impact of medical cannabis on health-related quality of life, this review delves into the Arkell et al. study in JAMA Network Open. With a focus on chronic pain patients, the research points to significant improvements across various health domains. Particularly, CBD-dominant cannabis products show promising results. Discover the key findings, strengths, and weaknesses of this impactful study.
Medical and recreational cannabis markets are likely to diverge further as scientific research reveals more therapeutic benefits of cannabis and its derivatives. This divergence stems from the demand for specific, evidence-based treatments for various medical conditions, which require accurate dosing, controlled formulations, and strict quality standards. On the other hand, recreational cannabis products are mainly designed for consumer satisfaction and preferences, with a wider range of product types and a continuous focus on THC potencies.
Explore the potential risks of excessive cannabis use, from short-term to long-term effects, with our comprehensive overview. Learn about the impact of THC and CBD concentrations in different cannabis chemovars, the dangers of large oral doses and edibles, and strategies for reducing these risks through responsible use and education.
In conclusion, the bibliographic analysis and table strongly implies that the ECS is an important area of research with a considerable impact on the scientific community. Despite the relatively lower number of publications compared to some other physiological systems, the high total citations and h-index for the ECS demonstrate its relevance and significance. The exclusion of the ECS from medical textbooks and education is therefore not only unprecedented but also unacceptable, given its importance in human physiology.
Researchers conducted a systematic review of studies investigating the use of cannabinoid-based medicines (CBMs) for chronic pain management and developed clinical practice guidelines based on the evidence. The review found that CBMs may provide benefits for chronic pain reduction, especially for neuropathic pain, and help with some co-occurring conditions. However, CBMs may cause some adverse events, and the optimal use of CBMs for chronic pain and co-occurring conditions is not clear. The guidelines provide practical recommendations for clinicians on patient education, assessment, dosing, administration routes, monitoring, and discontinuation of CBMs.
The endocannabinoid system (ECS) is a complex network of receptors, ligands, and enzymes that modulates various physiological processes in the human body. However, despite its critical role in human health and disease, the ECS and its components have not been adequately included in many popular medical textbooks, such as the ‘Guyton and Hall Textbook of Medical Physiology’. This article highlights the importance of incorporating the ECS and its therapeutic potential into medical education, as most doctors are not trained in the ECS and consequently have inadequate knowledge about the potential therapeutic uses of medical cannabis.